Reporting lung cancer pathology specimens. Impact of the anticipated 7th edition TNM classification based on recommendations of the IASLC staging committee

Histopathology

Volumn 54, Issue 1, 2009, Pages 3-11

  Travis, William D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Carcinoid; Lung cancer; Pathology; Pleural invasion; Specimen; Stage; Tumor size

Indexed keywords

CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CARCINOID; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; MEDICAL SOCIETY; MULTIPLE CANCER; PERICARDIAL EFFUSION; PLEURA CANCER; PLEURA EFFUSION; PLEURA METASTASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SMALL CELL CARCINOMA; TUMOR VOLUME;

CARCINOID TUMOR; CLASSIFICATION; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; PRACTICE GUIDELINES AS TOPIC; SMALL CELL LUNG CARCINOMA;

EID: 58649119064     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03179.x     Document Type: Review

References (58)

1. Sculier JP, Chansky K, Crowley JJ, Van MJ, Goldstraw P. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J. Thorac. Oncol. 2008 3 457 466.
2. Travis WD, Brambilla E, Rami-Porta R et al. Visceral pleural invasion: pathologic criteria and use of elastic stains: Proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol. 2008 3 1384 1390.
3. Travis WD, Giroux DJ, Chansky K et al. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for lung cancer. J Thorac Oncol. 2008 3 1213 1223.
4. Belcher E, Lawson MH, Nicholson AG, Davison A, Goldstraw P. Congenital cystic adenomatoid malformation presenting as in-flight systemic air embolisation. Eur. Respir. J. 2007 30 801 804.
5. Goldstraw P, Crowley J, Chansky K et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J. Thorac. Oncol. 2007 2 706 714.
6. Groome PA, Bolejack V, Crowley JJ et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J. Thorac. Oncol. 2007 2 694 705.
7. Postmus PE, Brambilla E, Chansky K et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J. Thorac. Oncol. 2007 2 686 693.
8. Rami-Porta R, Ball D, Crowley J et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J. Thorac. Oncol. 2007 2 593 602.
9. Rusch VW, Crowley J, Giroux DJ et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J. Thorac. Oncol. 2007 2 603 612.
10. Shepherd FA, Crowley J, Van HP et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J. Thorac. Oncol. 2007 2 1067 1077.
11. Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer; International Staging Project on Lung Cancer, 1st edn. J. Thoracic. Oncol. 2006 1 281 286.
12. Gal AA, Marchevsky AM, Travis WD. Updated protocol for the examination of specimens from patients with carcinoma of the lung. Arch. Pathol. Lab. Med. 2003 127 1304 1313.
13. Nash G, Hutter RV, Henson DE. Practice protocol for the examination of specimens from patients with lung cancer. Cancer Committee. Task Force on the Examination of Specimens from Patients with Lung Cancer. Arch. Pathol. Lab. Med. 1995 119 695 700.
14. Gibbs AR, Nicholson AG. Dataset for lung cancer histopathology reports, 2nd edn. London : Royal College of Pathologists, 2007.
15. Padilla J, Calvo V, Penalver JC, Sales G, Morcillo A. Surgical results and prognostic factors in early non-small cell lung cancer. Ann. Thorac. Surg. 1997 63 324 326.
16. Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marrogi AJ. Lung cancer staging: a case for a new T definition. Ann. Thorac. Surg. 2006 82 220 226.
17. Asamura H, Goya T, Koshiishi Y, Sohara Y, Tsuchiya R, Miyaoka E. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. J. Thorac. Cardiovasc. Surg. 2006 132 316 319.
18. Flieder DB, Port JL, Korst RJ et al. Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer. Chest 2005 128 2304 2308.
19. Takeda S, Fukai S, Komatsu H, Nemoto E, Nakamura K, Murakami M. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Ann. Thorac. Surg. 2005 79 1142 1146.
20. Carbone E, Asamura H, Takei H et al. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2001 122 907 912.
21. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Clinical tumour size prognosis in lung cancer. Eur. Respir. J. 1999 14 812 816.
22. Lopez-Encuentra A, Duque-Medina JL, Rami-Porta R, de la Camara AG, Ferrando P. Staging in lung cancer: is 3 cm a prognostic threshold in pathologic stage I non-small cell lung cancer? A multicenter study of 1,020 patients. Chest 2002 121 1515 1520.
23. UICC International Union Against Cancer. Explanatory notes for anatomic sites - general. In Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH eds. UICC International Union Against Cancer, TNM Supplement, A commentary on uniform use, 3rd edn. New York : John Wiley and Sons, Inc, 2003 1 24.
24. Hsu PK, Huang HC, Hsieh CC et al. Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. Ann. Thorac. Surg. 2007 84 1825 1829.
25. Sobin LH, Wittekind C eds. Introduction. In Sobin LH, Wittekind C eds. UICC International Union Against Cancer, TNM classification of malignant tumours, 6th edn. New York : Wiley-Liss, 2002 1 17.
26. Sobin LH, Wittekind C eds. Lung and pleural tumours. In Sobin LH, Wittekind C eds. UICC International Union Against Cancer, TNM classification of malignant tumours, 6th edn. New York : Wiley-Liss, 2002 97 107.
27. Rusch VW, Appelman HD, Byhardt R et al. Lung. In Greene FL, Page DL, Fleming ID et al. eds. AJCC cancer staging manual, 6th edn. New York : Springer-Verlag, 2002 167 181.
28. Battafarano RJ, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann. Thorac. Surg. 2002 74 988 993.
29. Roberts PF, Straznicka M, Lara PN et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J. Thorac. Cardiovasc. Surg. 2003 126 1597 1602.
30. Motoi N, Szoke J, Riely GJ et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am. J. Surg. Pathol. 2008 32 810 827.
31. UICC International Union Against Cancer. TNM Supplement, a commentary on uniform use, 3rd edn. New York : Wiley-Liss, 2003.
32. Hammar SP. Common tumors. In Dail DH, Hammar SP eds. Pulmonary pathology, 1st edn. New York : Springer-Verlag, 1988 727 845.
33. Hammar SP. Common tumors. In Dail DH, Hammar SP eds. Pulmonary pathology, 2nd edn. New York : Springer-Verlag, 1994 1138.
34. Kang JH, Kim KD, Chung KY. Prognostic value of visceral pleura invasion in non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 2003 23 865 869.
35. Manac'h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann. Thorac. Surg. 2001 71 1088 1093.
36. Osaki T, Nagashima A, Yoshimatsu T, Yamada S, Yasumoto K. Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance. Ann. Thorac. Surg. 2004 77 1769 1773.
37. Shimizu K, Yoshida J, Nagai K et al. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. J. Thorac. Cardiovasc. Surg. 2004 127 1574 1578.
38. Shimizu K, Yoshida J, Nagai K et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2005 130 160 165.
39. Martini N, Bains MS, Burt ME et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J. Thorac. Cardiovasc. Surg. 1995 109 120 129.
40. Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size. Chest 2008 133 662 669.
41. Gephardt GN, Baker PB. Lung carcinoma surgical pathology report adequacy: a College of American Pathologists Q-Probes study of over 8300 cases from 464 institutions. Arch. Pathol. Lab. Med. 1996 120 922 927.
42. Taube JM, Askin FB, Brock MV, Westra W. Impact of elastic staining on the staging of peripheral lung cancers. Am. J. Surg. Pathol. 2007 31 953 956.
43. Butnor KJ, Vollmer RT, Blaszyk H, Glatz K. Interobserver agreement on what constitutes visceral pleural invasion by non-small cell lung carcinoma: an internet-based assessment of international current practices. Am. J. Clin. Pathol. 2007 128 638 647.
44. Bunker ML, Raab SS, Landreneau RJ, Silverman JF. The diagnosis and significance of visceral pleural invasion in lung carcinoma. Histologic predictors and the role of elastic stains. Am. J. Clin. Pathol. 1999 112 777 783.
45. Demir A, Gunluoglu MZ, Sansar D, Melek H, Dincer SI. Staging and resection of lung cancer with minimal invasion of the adjacent lobe. Eur. J. Cardiothorac. Surg. 2007 32 855 858.
46. Miura H, Taira O, Uchida O, Kato H. Invasion beyond interlobar pleura in non-small cell lung cancer. Chest 1998 114 1301 1304.
47. Okada M, Tsubota N, Yoshimura M, Miyamoto Y, Matsuoka H. How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer. Ann. Thorac. Surg. 1999 68 2049 2052.
48. UICC International Union Against Cancer. Explanatory notes for anatomic sites - lung. In Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH eds. UICC International Union Against Cancer, TNM Supplement, a commentary on uniform use, 3rd edn. New York : John Wiley and Sons, Inc, 2003 47 49.
49. Asamura H, Kameya T, Matsuno Y et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J. Clin. Oncol. 2006 24 70 76.
50. Cardillo G, Sera F, Di MM et al. Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann. Thorac. Surg. 2004 77 1781 1785.
51. Filosso PL, Rena O, Donati G et al. Bronchial carcinoid tumors: surgical management and long-term outcome. J. Thorac. Cardiovasc. Surg. 2002 123 303 309.
52. Marty-Ane CH, Costes V, Pujol JL, Alauzen M, Baldet P, Mary H. Carcinoid tumors of the lung: do atypical features require aggressive management? Ann. Thorac. Surg. 1995 59 78 83.
53. McCaughan BC, Martini N, Bains MS. Bronchial carcinoids. Review of 124 cases. J. Thorac. Cardiovasc. Surg. 1985 89 8 17.
54. Mezzetti M, Raveglia F, Panigalli T et al. Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification. Ann. Thorac. Surg. 2003 76 1838 1842.
55. Travis WD, Rush W, Flieder DB et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am. J. Surg. Pathol. 1998 22 934 944.
56. Beasley MB, Thunnissen FB, Brambilla E et al. Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum. Pathol. 2000 31 1255 1265.
57. Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH eds. Lung. In Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH eds. UICC International Union Against Cancer, TNM Supplement, a commentary on uniform use, 3rd edn. New York : Wiley-Liss, 2003 47, 97, 143-149, 98, 144.
58. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother. Rep. 1973 4 31 42.